发明名称 Heteroaryl compounds useful as inhibitors of E1 activating enzymes
摘要 This invention relates to compounds that inhibit E1 activating enzymes, pharmaceutical compositions comprising the compounds, and methods of using the compounds. The compounds are useful for treating disorders, particularly cell proliferation disorders, including cancers, inflammatory and neurodegenerative disorders; and inflammation associated with infection and cachexia.
申请公布号 US9458108(B2) 申请公布日期 2016.10.04
申请号 US201514827556 申请日期 2015.08.17
申请人 Millennium Pharmaceuticals, Inc. 发明人 Claiborne Christopher F.;Critchley Stephen;Langston Steven P.;Mizutani Hirotake;Olhava Edward J.;Peluso Stephane;Vyskocil Stepan;Weatherhead Gabriel S.
分类号 C07D213/56;A61K31/443;C07D213/82;C07D213/69;C07D239/42;C07D401/04;C07D403/04;C07D471/04;C07D471/08;C07D473/34;C07D473/30;A61K31/53;C07D251/18;C07D251/48;C07D213/74;C07D401/06;C07D487/04 主分类号 C07D213/56
代理机构 Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P. 代理人 Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.
主权项 1. A compound of formula (II): or a pharmaceutically acceptable salt thereof, wherein: D is —C(Rh)═; E is —C(Rh)═; Rg is hydrogen, halo, cyano, —C(R5)═C(R5)2, —C≡C—R5, —OR5, —SR6, —S(O)R6, —SO2R6, —SO2N(R4)2, —N(R4)2, —NR4C(O)R5, —NR4C(O)N(R4)2, —N(R4)C(═NR4)—N(R4)2, —N(R4)C(═NR4)—R6, —NR4CO2R6, —N(R4)SO2R6, —N(R4)SO2N(R4)2, —O—C(O)R5, —OCO2R6, —OC(O)N(R4)2, —C(O)R5, —CO2R5, —C(O)N(R4)2, —C(O)N(R4)—OR5, —C(O)N(R4)C(═NR4)—N(R4)2, —N(R4)C(═NR4)—N(R4)—C(O)R5, —C(═NR4)—N(R4)2, —C(═NR4)—OR5, —N(R4)—N(R4)2, —N (R4)—OR5, —C(═NR4)—N(R4)—OR5, —C(R6)═N—OR5, or an optionally substituted aliphatic, aryl, heteroaryl, or heterocyclyl; and each Rh independently is hydrogen, halo, —CN—, —OR5, —N(R4)2, —SR6, or an optionally substituted C1-4 aliphatic group; W is —CH2—, —CHF—, —CF2—, —CH(R1)—, —CF(R1)—, —NH—, —N(R1)—, —O—, —S—, or —NHC(O)—; R1 is C1-4 aliphatic or C1-4 fluoroaliphatic; X is —CH2—, —CHF—, —CF2—, —NH—, or —O—; Y is —O—, —S—, or —C(Rm)(Rn)—; Ra is hydrogen, fluoro, —CN, —N3, —OR5, —N(R4)2, —NR4CO2R6, —NR4C(O)R5, —C(O)N(R4)2, —C(O) R5, —OC(O)N(R4)2, —OC(O)R5, —OCO2R6, or a C1-4 aliphatic or C1-4 fluoroaliphatic optionally substituted with one or two substituents independently selected from —OR5x, —N(R4x)(R4y), —CO2R5x, or —C(O)N(R4x)(R4y); or Ra and Rc together form a bond; Rb is hydrogen, fluoro, C1-4 aliphatic, or C1-4 fluoroaliphatic; Rc is hydrogen, fluoro, —CN, —N3, —OR5, —N(R4)2, —NR4CO2R6, —NR4C(O)R5, —C(O)N(R4)2, —C(O)R5, —OC(O)N(R4)2, —OC(O)R5, —OCO2R6, or a C1-4 aliphatic or C1-4 fluoroaliphatic optionally substituted with one or two substituents independently selected from —OR5x, —N(R4x)(R4y), —CO2R5x, or —C(O)N(R4x)(R4y); or Ra and Ro together form a bond; Rd is hydrogen, fluoro, C1-4 aliphatic, or C1-4 fluoroaliphatic; Re is hydrogen, or C1-4 aliphatic; or Re, taken together with one Rf and the intervening carbon atoms, forms a 3- to 6-membered spirocyclic ring; or Re, taken together with Rm and the intervening carbon atoms, forms a fused cyclopropane ring, which is optionally substituted with one or two substituents independently selected from fluoro or C1-4 aliphatic; Re′ is hydrogen or C1-4 aliphatic; or Re′, taken together with Rm and the intervening carbon atoms, forms a fused cyclopropane ring, which is optionally substituted with one or two substituents independently selected from fluoro or C1-4 aliphatic; each Rf is independently hydrogen, fluoro, C1-4 aliphatic, or C1-4 fluoroaliphatic; or two Rf taken together form ═O; or two Rf, taken together with the carbon atom to which they are attached, form a 3- to 6-membered carbocyclic ring; or one Rf, taken together with Re and the intervening carbon atoms, forms a 3- to 6-membered spirocyclic ring; Rm is hydrogen, fluoro, —N(R4)2, or an optionally substituted C1-4 aliphatic group; or Rm and Rn together form ═O or ═C(R5)2; or Rm and Re, taken together with the intervening carbon atoms, form a fused cyclopropane ring, which is optionally substituted with one or two substituents independently selected from fluoro or C1-4 aliphatic; or Rm and Re′, taken together with the intervening carbon atoms, form a fused cyclopropane ring, which is optionally substituted with one or two substituents independently selected from fluoro or C1-4 aliphatic; Rn is hydrogen, fluoro, or an optionally substituted C1-4 aliphatic group; or Rm and Rn together form ═O or ═C(R5)2; each R4 independently is hydrogen or an optionally substituted aliphatic, aryl, heteroaryl, or heterocyclyl group; or two R4 on the same nitrogen atom, taken together with the nitrogen atom, form an optionally substituted 4- to 8-membered heterocyclyl ring having, in addition to the nitrogen atom, 0-2 ring heteroatoms independently selected from N, O, and S; R4x is hydrogen, C1-4 alkyl, C1-4 fluoroalkyl, or C6-10 ar(C1-4)alkyl, the aryl portion of which may be optionally substituted; R4y is hydrogen, C1-4 alkyl, C1-4 fluoroalkyl, C6-10 ar(C1-4)alkyl, the aryl portion of which may be optionally substituted, or an optionally substituted 5- or 6-membered aryl, heteroaryl, or heterocyclyl ring; or R4x and R4y, taken together with the nitrogen atom to which they are attached, form an optionally substituted 4- to 8-membered heterocyclyl ring having, in addition to the nitrogen atom, 0-2 ring heteroatoms independently selected from N, O, and S; and each R5 independently is hydrogen or an optionally substituted aliphatic, aryl, heteroaryl, or heterocyclyl group; each R5x independently is hydrogen, C1-4 alkyl, C1-4 fluoroalkyl, or an optionally substituted C6-10 aryl or C6-10 ar(C1-4)alkyl; each R6 independently is an optionally substituted aliphatic, aryl, or heteroaryl group; and m is 1, 2, or 3.
地址 Cambridge MA US